![](/img/cover-not-exists.png)
Use of 4β‐hydroxycholesterol plasma concentrations as an endogenous biomarker of CYP 3A activity: Clinical validation in individuals with type 2 diabetes
Gravel, Sophie, Chiasson, Jean‐Louis, Gaudette, Fleur, Turgeon, Jacques, Michaud, VeroniqueJournal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt.1472
Date:
April, 2019
File:
PDF, 390 KB
2019